BMY AI forecast — Bristol-Myers Squibb Company

Hedgewing's neural-network ensemble rates BMY a Buy as of . 1-day forecast: $62.49 (+1.83%). Last close $59.56 (-2.92%).

5-day and 20-day price targets, model confidence, and the full AI analysis are available with a free account.